Sulfadiazine
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Sulfadiazine
|
|
| Systematic (IUPAC) name | |
| 4-amino-N-pyrimidin-2-yl-benzenesulfonamide | |
| Identifiers | |
| CAS number | 68-35-9 |
| ATC code | J01EC02 |
| PubChem | 2215 |
| DrugBank | APRD00190 |
| Chemical data | |
| Formula | C10H10N4O2S |
| Mol. weight | 358.146 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Approved Drug |
| Routes | Cream |
Sulfadiazine is a sulphonamide. It eliminates bacteria that cause infections by stopping the production of folic acid[1] inside the bacterial cell, and is used to treat urinary tract infections.
Side effects reported for Sulfadiazine include nausea, upset stomach, or loss of appetite; dizziness;
[edit] Brand Names
Lantrisul; Neotrizine; Sulfa-Triple #2; Sulfadiazine; Sulfaloid; Sulfonamides Duplex; Sulfose; Terfonyl; Triple Sulfa; Triple Sulfas; Triple Sulfoid
[edit] See also
[edit] External links
- Sulfadiazine (patient information)
- Links to external chemical sources.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
